Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis.
| Publicado en: | Journal of Clinical Oncology Vol. 40; pp. 1055 - 1056 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2022 Supplement 16
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183145941&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 183145941 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2022 Supplement 16 vid: 40 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 183145941 10.1200/JCO.2022.40.16_suppl.1055 183145941 ppf: 1055 ppct: 1 formats: tig: atl: Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis. aug: au: O'Shaughnessy, Joyce Woeckel, Achim Pistilli, Barbara Hegg, Roberto Vahdat, Linda T. Vuina, Dragica Asad ZVK, Parisa Smith, Timothy W Kim, Julia Krop, Ian affil: Baylor University Medical Center, Texas Oncology, US Oncology Network, Dallas, TX sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|